who is not a good candidate for semaglutide The Pros, Cons, and Considerations of Taking Ozempic and Other GLP-1 Drugs Weight Loss Who Should Not Take Semaglutide?

Key Takeaways Tirzepatide is a dual GIP and GLP-1 receptor agonist FDA-approved for chronic weight management in adults with obesity or overweight

As they age, they produce less energy and more damaging by-products

Holst AG, Jensen G, Prescott E (2010) Risk factors for venous thromboembolism: results from the Copenhagen city heart study

However, understanding your individual peptide-pathway genetics helps optimize semaglutide dosing, which indirectly affects how your stomach processes all medications, including antibiotics

Doses are then gradually increased every four weeks, under the guidance of a healthcare provider, to allow your body to adjust